Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowNet Cash FlowNet Cash FlowNet IncomeOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rallybio (RLYB) Capital Expenditures (2023)

Rallybio (RLYB) has disclosed Capital Expenditures for 1 consecutive years, with $12000.0 as the latest value for Q3 2023.

  • Quarterly Capital Expenditures changed N/A to $12000.0 in Q3 2023 from the year-ago period, while the trailing twelve-month figure was $12000.0 through Dec 2024, changed 0.0% year-over-year, with the annual reading at $12000.0 for FY2023, 77.78% down from the prior year.
  • Capital Expenditures hit $12000.0 in Q3 2023 for Rallybio.
  • In the past five years, Capital Expenditures ranged from a high of $12000.0 in Q3 2023 to a low of $12000.0 in Q3 2023.